FDA Panel report: January 1998.
Thadani
U
U
Roden
D M
DM
D057911:Angiotensin Receptor Antagonists; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D000077542:Eptifibatide; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*; D017202:Myocardial Ischemia / Q000188:drug therapy*; D010455:Peptides / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D014481:United States; D014486:United States Food and Drug Administration
D057911:Angiotensin Receptor Antagonists; D002316:Cardiotonic Agents; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D000077542:Eptifibatide